Frequently asked questions

Questions before you begin?

Find clear answers about the EVO assessment, treatment pathways, support and what to expect throughout your weight-management journey.

General

About EVO

General questions about the EVO Wellness Center approach.

EVO Wellness Center provides a structured approach to weight-management support, beginning with an assessment and considering treatment options, individual circumstances, safety and ongoing support.
No. You can indicate a preference if you have one, but you can also select that you are unsure. The assessment is designed to collect relevant information before appropriate next steps are considered.
EVO focuses on weight-management pathways that may include medication where appropriate, but sustainable habits, nutrition, activity and broader wellness remain important parts of the journey.
Assessment

About the health assessment

Weight-management treatment should be considered alongside relevant health information. The assessment collects details such as your health history, current medication, goals and previous treatment experience for clinician review.
No. Completing the assessment only submits your information for review. It does not confirm eligibility or guarantee that a particular treatment will be appropriate.
Your submission is recorded with an EVO reference number and marked for clinician review. The information can then be reviewed before the appropriate next step is communicated to you.
Health information should be handled carefully and with appropriate access controls. EVO's assessment system is designed to keep the detailed questionnaire within the website's private review area rather than placing the full questionnaire in routine email notifications.
Treatments

Treatment questions

The website currently provides information about Tirzepatide, Semaglutide and Retatrutide. Availability, permitted use and suitability can differ, so listing a treatment does not mean it is automatically available or appropriate.
You can state a preference, but the final treatment pathway should consider health information, individual circumstances, treatment status, availability and clinician review.
No. Semaglutide acts primarily through the GLP-1 pathway, while Tirzepatide acts across GLP-1 and GIP pathways. Mechanistic differences alone do not determine which option may be appropriate for a particular person.
Retatrutide is presented in an educational and enquiry-led way because availability and treatment status should be established before it is presented like a routine treatment option.
Results

What should I expect?

There is no guaranteed timeline. Individual response can vary based on biology, treatment, duration, lifestyle, health history and other personal factors.
No. Weight-management outcomes vary between individuals. EVO should not promise a particular amount or speed of weight loss.
Healthy eating patterns, movement, sleep, consistency and other lifestyle factors remain important even when medication forms part of a weight-management plan.
Safety

Health and side effects

Yes. Medicines used in weight management can cause side effects, including gastrointestinal symptoms and other reactions. The specific risks vary by treatment and individual circumstances.
You should include your current medicines in the assessment. Existing medication can be relevant when a clinician reviews treatment suitability and possible interactions or precautions.
Pregnancy, breastfeeding and pregnancy-planning circumstances should be disclosed during assessment because they can be relevant to treatment suitability.
Do not wait for an online assessment response if you are seriously unwell or experiencing an emergency. Seek appropriate urgent medical care.
Support

Delivery and continued care

Where applicable, treatment delivery may be arranged depending on location, treatment availability and the relevant care pathway. Delivery details should be confirmed before an order is finalised.
EVO is designed around a more complete weight-management journey. Continued guidance and follow-up may form part of the pathway rather than treatment being treated as a one-off purchase.
The assessment allows you to provide your contact details and preferred contact method. The EVO team can then use those details when following up on your submission.

Still not sure where to start?

You do not need to choose a treatment before beginning. Complete your EVO assessment and let your health information guide the next step.

Start your assessment →